glp 1 drug makers Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs. Even so, they're already outlining their visions for the future of obesity drugs Patients' Use GLP-1 Drugs for

Mexico 15.4

Based on rigorous instrumental variable selection procedure, drug target MR uses genetic variants to simulate the agonistic effects of drug targets, helping to evaluate their long-term exposure impact on diseases [20,21]

Glucagon-like peptide analogs are superior for diabetes and weight control in patients on antipsychotic medications: a retrospective cohort study

Muskiet MHA, Tonneijck L, Smits MM, et al

Legro, Penn State Clinical and Translational Institute, USA Rong Li, Peking University Third Hospital, China Marla Lujan, Cornell University, USA Ronald Ma, Chinese University of Hong Kong, Hong Kong /China Darren Mansfield, Monash and Epworth Health, Monash University, Australia Kate Marsh, Northside Nutrition & Dietetics, Australia Edgar Mocanu, Rotunda Hospital, Ireland Ben Mol, Monash University, Australia Rachel Mormon, VerityPCOS Charity, UK Sharon Oberfield, Columbia University Medical Center, USA Malika Patel, University of Cape Town